Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore

Divis Labs

Indian pharmaceutical giant Divi's Labs' on November 9 reported a net profit of Rs 510 crore, up 46.5 percent for the second quarter of financial year 2024-2025 (Q2FY25). It had reported a net profit of Rs 348 crore in Q2FY24.

For Q2FY25, it reported revenue at Rs 2,338 crore, up 22.5 percent YoY.

Divi's Laboratories reported a 49.5 percent year-on-year growth in its EBITDA, reaching Rs 716 crore for the quarter ending September 2023, compared to Rs 479 crore in the same period last year. The company also saw a significant increase in its Q2 margin, rising by 500 basis points to 30.6 percent, up from 25 percent in the previous year.

For the half-year period ending September 30, the company reported a consolidated total income of Rs 4,640 crore, compared to Rs 3,854 crore for the same period last year.

The company's PAT for the current half-year stood at Rs 940 crore, up from Rs 704 crore in the same period last year. Additionally, it reported a forex gain of Rs 28 crore, compared to Rs 14 crore in the previous year.